X0306 4 2022-03-04 0 0000818686 TEVA PHARMACEUTICAL INDUSTRIES LTD TEVA 0001876642 Shani Eli C/O TEVA PHARMACEUTICAL INDUSTRIES LTD. 124 DVORA HANEVI'A ST., TEL AVIV L3 6944020 ISRAEL 0 1 0 0 EVP,Global Marketing&Portfolio Ordinary Shares 2022-03-04 4 M 0 3173 A 12264 D Ordinary Shares 2022-03-05 4 M 0 5896 A 18160 D Restricted Share Units 2022-03-04 4 M 0 3173 0.00 D Ordinary Shares 3173 3173 D Restricted Share Units 2022-03-04 4 A 0 80428 0.00 A Ordinary Shares 80428 80428 D Restricted Share Units 2022-03-05 4 M 0 5896 0.00 D Ordinary Shares 5896 17690 D The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. Restricted share units were granted on March 4, 2019, with 3,173 vesting on each of March 4 2022 and March 4, 2023. Restricted share units were granted on March 4, 2022, with 20,107 vesting on each of March 4, 2023, March 4, 2024, March 4, 2025 and March 4, 2026. Restricted share units were granted on March 5, 2021, with 5,896 having vested on March 5, 2022, 5,896 vesting on each of March 5, 2023 and March 5, 2024, and 5,898 vesting on March 5, 2025. /s/ Dov Bergwerk as attorney-in-fact for Eli Shani 2022-03-08